Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

• Váldodahkkit: Hirsch Matani (Dahkki), Divya Sahu (Dahkki), Michael Paskewicz (Dahkki), Anastasia Gorbunova (Dahkki), Ashten N. Omstead (Dahkki), Rodney Wegner (Dahkki), Gene G. Finley (Dahkki), Blair A. Jobe (Dahkki), Ronan J. Kelly (Dahkki), Ali H. Zaidi (Dahkki), Ajay Goel (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Esophageal adenocarcinoma is a lethal disease. For locally advanced patients, neoadjuvant chemoradiotherapy followed by surgery is the standard of care. Risk stratification relies heavily on clinicopathologic features, particularly pathologic response, which is inadequate, theref...